Companies: 10,795·Total market cap: $144.5T
Quantum-Si incorporated

Quantum-Si incorporated

QSINASDAQHealthcare● Active
$1.06
+$0.01(+0.95%)
Market Cap$209692023
P/E Ratio
52W High$3.1
52W Low$0.691

Quantum-Si incorporated (QSI) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

qsi · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Quantum-Si incorporated (QSI) measures how much investors pay for each dollar of the company's trailing earnings. QSI's current PE ratio of N/A is calculated by dividing its stock price of $1.06 by its TTM earnings per share of -$0.48.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.40
Based on 1 analyst
EPS (TTM)
-$0.48
TTM · diluted EPS
PEG Ratio
-0.08
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Quantum-Si incorporated SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Quantum-Si incorporated
Quantum-Si incorporatedYou
QSI
$210MN/A-$0.48
ADC Therapeutics S.A.
ADC Therapeutics S.A.
ADCT
$124MN/A-$1.12
Altimmune, Inc.
Altimmune, Inc.
ALT
$241MN/A-$1.00
Annexon, Inc.
Annexon, Inc.
ANNX
$612MN/A-$1.33
Aura Biosciences, Inc.
Aura Biosciences, Inc.
AURA
$416MN/A-$1.76
Autolus Therapeutics plc
Autolus Therapeutics plc
AUTL
$389MN/A-$1.08
DBV Technologies S.A.
DBV Technologies S.A.
DBVT
$383MN/A-$1.70

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.51
2024-12-31
FY2024
$-0.71
2023-12-31
FY2023
$-0.68
2022-12-31
FY2022
$-0.95
2021-12-31
FY2021
$-1.19
2020-12-31
FY2020
$-6.81
2019-12-31
FY2019
$-0.26

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Quantum-Si incorporated (QSI) measures how much investors pay for each dollar of the company's trailing earnings. QSI's current PE ratio of N/A is calculated by dividing its stock price of $1.06 by its TTM earnings per share of -$0.48.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.06 ÷ -$0.48 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

QSI pe ratio · 6 questions

QSI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.06 and TTM EPS of -$0.48. Data sourced from Financial Modeling Prep via QSI's SEC 10-K and 10-Q filings.

QSI PE ratioWhat is QSI PE ratioCurrent PE ratio of QSIQSI PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Quantum-Si incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09